Opioids in the United Kingdom: safety and surveillance during COVID-19 | Zendy

Vicki Osborne | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Opioids in the United Kingdom: safety and surveillance during COVID-19

Author(s) -

Vicki Osborne

Publication year - 2021

Publication title -

current opinion in psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.66

H-Index - 90

eISSN - 1473-6578

pISSN - 0951-7367

DOI - 10.1097/yco.0000000000000719

Subject(s) - pandemic , medicine , covid-19 , health care , agency (philosophy) , medical emergency , political science , disease , philosophy , epistemology , pathology , infectious disease (medical specialty) , law

Opioid use is prevalent in the United Kingdom and prior to the COVID-19 pandemic it had been recognized that the safety of opioids was an important issue to be monitored by the UK medicines regulatory agency. With the emergence of COVID-19, this requirement has been even greater. This review was undertaken to determine the impact of the pandemic on safety and surveillance of opioids in the United Kingdom.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research